Clinical Trials Browser

Phase 3 × INDUSTRY × luprolide acetate gel depot × Clear all

NCT02319837 2025-07-08

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

Phase 3 Active not recruiting

1,068 enrolled 20 charts 1 FDA

Prostatic Neoplasms

NCT00378690 2014-06-04

ICELAND

Phase 3 Completed

Prostatic Neoplasms

NCT00514917 2013-11-04

Rising PSA

Phase 3 Terminated

413 enrolled 21 charts

Prostatic Neoplasms

NCT00283062 2012-01-26

Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy

Phase 3 Completed

228 enrolled 14 charts

Prostatic Neoplasms